108 related articles for article (PubMed ID: 9845074)
1. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation.
Zheng P; Guo Y; Niu Q; Levy DE; Dyck JA; Lu S; Sheiman LA; Liu Y
Nature; 1998 Nov; 396(6709):373-6. PubMed ID: 9845074
[TBL] [Abstract][Full Text] [Related]
2. Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer.
Zhang H; Melamed J; Wei P; Cox K; Frankel W; Bahnson RR; Robinson N; Pyka R; Liu Y; Zheng P
Cancer Immun; 2003 Feb; 3():2. PubMed ID: 12747744
[TBL] [Abstract][Full Text] [Related]
3. Concordant expression of proto-oncogene promyelocytic leukemia and major histocompatibility antigen HLA class I in human hepatocellular carcinoma.
Xia M; Zhang JQ; Shen YQ; Xu LH; Chen AQ; Miao FQ; Xie W
Tissue Antigens; 2007 Oct; 70(4):272-82. PubMed ID: 17767548
[TBL] [Abstract][Full Text] [Related]
4. The PML gene is not involved in the regulation of MHC class I expression in human cell lines.
Bruno S; Ghiotto F; Fais F; Fagioli M; Luzi L; Pelicci PG; Grossi CE; Ciccone E
Blood; 2003 May; 101(9):3514-9. PubMed ID: 12506025
[TBL] [Abstract][Full Text] [Related]
5. Proto-oncogene PML enhances antigen presentation by MHC class I molecules in human lung cancer cells.
Chang SK; Park B; Shin J; Ahn JH; Kim IH; Ahn K
Mol Cells; 2002 Aug; 14(1):130-5. PubMed ID: 12243342
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens.
Larghero J; Zassadowski F; Rousselot P; Padua RA; Degos L; Chomienne C
Leukemia; 1999 Aug; 13(8):1295-6. PubMed ID: 10450763
[No Abstract] [Full Text] [Related]
7. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.
Romero I; Martinez M; Garrido C; Collado A; Algarra I; Garrido F; Garcia-Lora AM
J Pathol; 2012 Jul; 227(3):367-79. PubMed ID: 22451343
[TBL] [Abstract][Full Text] [Related]
8. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
9. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
[TBL] [Abstract][Full Text] [Related]
10. Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.
Manning J; Indrova M; Lubyova B; Pribylova H; Bieblova J; Hejnar J; Simova J; Jandlova T; Bubenik J; Reinis M
Immunology; 2008 Feb; 123(2):218-27. PubMed ID: 17725605
[TBL] [Abstract][Full Text] [Related]
11. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly.
Hengel H; Flohr T; Hämmerling GJ; Koszinowski UH; Momburg F
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2287-96. PubMed ID: 8811029
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes.
Lee CK; Gimeno R; Levy DE
J Exp Med; 1999 Nov; 190(10):1451-64. PubMed ID: 10562320
[TBL] [Abstract][Full Text] [Related]
14. Multiple levels of MHC class I down-regulation by ras oncogenes.
Lohmann S; Wollscheid U; Huber C; Seliger B
Scand J Immunol; 1996 May; 43(5):537-44. PubMed ID: 8633212
[TBL] [Abstract][Full Text] [Related]
15. The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors.
Seliger B
J Immunotoxicol; 2014 Oct; 11(4):308-10. PubMed ID: 24479372
[TBL] [Abstract][Full Text] [Related]
16. Antigen processing and presentation by the class I major histocompatibility complex.
York IA; Rock KL
Annu Rev Immunol; 1996; 14():369-96. PubMed ID: 8717519
[TBL] [Abstract][Full Text] [Related]
17. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation.
Yewdell J; Lapham C; Bacik I; Spies T; Bennink J
J Immunol; 1994 Feb; 152(3):1163-70. PubMed ID: 8301122
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation.
Lammert E; Arnold D; Rammensee HG; Schild H
Eur J Immunol; 1996 Apr; 26(4):875-9. PubMed ID: 8625982
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein.
Vallian S; Gäken JA; Gingold EB; Kouzarides T; Chang KS; Farzaneh F
Oncogene; 1998 Jun; 16(22):2843-53. PubMed ID: 9671405
[TBL] [Abstract][Full Text] [Related]
20. Viral immune evasion: Lessons in MHC class I antigen presentation.
van de Weijer ML; Luteijn RD; Wiertz EJ
Semin Immunol; 2015 Mar; 27(2):125-37. PubMed ID: 25887630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
